Pulmonary Manifestations of Ankylosing Spondylitis

Clinics in Chest Medicine

Volumn 31, Issue 3, 2010, Pages 547-554

  Kanathur, Naveen ^a   Lee Chiong, Teofilo ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

Ankylosing spondylitis; Apical fibrobullous disease; Chest wall restriction; Spontaneous pneumothorax

Indexed keywords

ADALIMUMAB; ANTIINFECTIVE AGENT; DIFLUNISAL; ETANERCEPT; HLA B27 ANTIGEN; INFLIXIMAB; PHENYLBUTAZONE; TUMOR NECROSIS FACTOR ANTIBODY;

ANKYLOSING SPONDYLITIS; APICAL FIBROBULLOUS DISEASE; BACKACHE; BACTERIAL SUPERINFECTION; BRONCHIECTASIS; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; GENETIC SUSCEPTIBILITY; HEMOPTYSIS; HISTOPATHOLOGY; HUMAN; LOBECTOMY; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG INFECTION; LUNG TUBERCULOSIS; MORNING STIFFNESS; MYCETOMA; PATHOGENESIS; PLEURA EFFUSION; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; SACROILIITIS; SLEEP APNEA SYNDROME; SPONTANEOUS PNEUMOTHORAX; THORACOTOMY; THORAX RADIOGRAPHY; UNSPECIFIED SIDE EFFECT; UREMIA;

EID: 77955409712     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2010.05.002     Document Type: Review

References (68)

1. Bulwark D.W., Weissman D.N., Doll N.J. Pulmonary manifestations of rheumatic diseases. Clin Rev Allergy 1985, 3:249-267.
2. Gupta S.M., Johnston W.H. Apical pulmonary disease in ankylosing spondylitis. N Z Med J 1978, 88:186-188.
3. Hunninghake G.W., Fauci A.S. Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 1979, 119:471-503.
4. Rumancik W.M., Firooznia H., Davis M.S., et al. Fibrobullous disease of the upper lobes: an extraskeletal manifestation of ankylosing spondylitis. J Comput Tomogr 1984, 8:225-229.
5. Tanoue L.T. Pulmonary involvement in collagen vascular disease: a review of the pulmonary manifestations of the Marfan syndrome, ankylosing spondylitis, Sjogren's syndrome and relapsing polychondritis. J Thorac Imaging 1992, 7:62-77.
6. Wiedemann H.P., Matthay R.A. Pulmonary manifestations of the collagen vascular diseases. Clin Chest Med 1989, 10:677-722.
7. Wolson A.H., Rohwedder J.J. Upper lobe fibrosis in ankylosing spondylitis. Am J Roentgenol Radium Ther Nucl Med 1975, 124:466-471.
8. Calin A., Fries J.F. Striking prevalence of ankylosing spondylitis in " healthy" W27 positive males and females. N Engl J Med 1975, 293:835-839.
9. Hurwitz S.S., Conlan A.A., Krige L.P. Fibrocavitating pulmonary lesions in ankylosing spondylitis. S Afr Med J 1982, 61:168-170.
10. Prakash S., Mehra N.K., Bhargava S., et al. Ankylosing spondylitis in North India: a clinical and immunogenetic study. Ann Rheum Dis 1984, 43:381-385.
11. Beaulieu A.D., Rousseau F., Israel-Assayag E., et al. Klebsiella related antigens in ankylosing spondylitis. J Rheumatol 1983, 10:102-105.
12. Blumberg B., Ragan C. The natural history of rheumatoid spondylitis. Medicine 1956, 35:1-31.
13. Appelrouth D., Gottlieb N.L. Pulmonary manifestations of ankylosing spondylitis. J Rheumatol 1975, 2:446-453.
14. Blavia R., Toda M.R., Vidal F., et al. Pulmonary diffuse amyloidosis and ankylosing spondylitis. Chest 1992, 102:1608-1610.
15. Dunham C.L., Kautz F.G. Spondylarthritis ankylopoietica. A review and report of twenty cases. Am J Med Sci 1941, 201:232-250.
16. Hamilton K.A. Pulmonary disease manifestations of ankylosing spondylarthritis. Ann Intern Med 1949, 31:216-227.
17. Rosenow E., Strimlan C.V., Muhm J.R., et al. Pleuropulmonary manifestations of ankylosing spondylitis. Mayo Clin Proc 1977, 52:641-649.
18. Libby D.M., Schley W.S., Smith J.P. Cricoarytenoid arthritis in ankylosing spondylitis. A cause of acute respiratory failure and cor pulmonale. Chest 1981, 80:641-643.
19. Sinclair J.R., Mason R.A. Ankylosing spondylitis. The case for awake intubation. Anaesthesia 1984, 39:3-11.
20. Shankar P.S. Ankylosing spondylitis with fibrosis and carcinoma of the lung. CA Cancer J Clin 1982, 32:177-179.
21. Fournie B., Boutes A., Dromer C., et al. Prospective study of anterior chest wall involvement in ankylosing spondylitis and psoriatic arthritis. Rev Rhum Engl Ed 1997, 64:22-25.
22. Kentala E., Repo U.K., Lehtipuu A.L., et al. HLA-antigens and pulmonary upper lobe fibrocystic changes with and without ankylosing spondylitis. Scand J Respir Dis 1978, 59:8-12.
23. Hillerdal G. Ankylosing spondylitis lung disease-an underdiagnosed entity?. Eur J Respir Dis 1983, 64:437-441.
24. Repo U.K., Kentala E., Koistinen J., et al. Pulmonary apical fibrocystic disease. Eur J Respir Dis 1981, 62:46-55.
25. Crompton G.K., Cameron S.J., Langlands A.O., et al. Pulmonary fibrosis, mimicking tuberculosis, presenting before joint symptoms in a female with ankylosing spondylitis. Tubercle 1973, 54:317-320.
26. Ferdoutis M., Bouros D., Meletis G., et al. Diffuse interstitial lung disease as an early manifestation of ankylosing spondylitis. Respiration 1995, 62:286-289.
27. Stewart R.M., Ridyard J.B., Pearson J.D. Regional lung function in ankylosing spondylitis. Thorax 1976, 31:433-437.
28. Jessamine A.G. Upper lobe fibrosis in ankylosing spondylitis. Can Med Assoc J 1968, 98:25-29.
29. Scobie B.A. Disturbed oesophageal manometric responses in patients with ankylosing spondylitis and pulmonary aspergilloma. Australas Ann Med 1970, 19:131-134.
30. Campbell A.H., MacDonald C.B. Upper lobe fibrosis associated with ankylosing spondylitis. Br J Dis Chest 1965, 59:90-101.
31. Parkin A., Phil D., Robinson P.J., et al. Regional lung ventilation in ankylosing spondylitis. Br J Radiol 1982, 55:833-836.
32. Zorab P.A. The lungs in ankylosing spondylitis. Q J Med 1962, 31:267-280.
33. Hart F.D., Emerson P.A., Gregg I. Thorax in ankylosing spondylitis. Ann Rheum Dis 1963, 22:11-18.
34. Court-Brown W.M., Doll R. Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br Med J 1965, 2:1327-1332.
35. Zizzo G., Castriota-Scanderbeg A., Zarrelli N., et al. Pulmonary aspergillosis complicating ankylosing spondylitis. Radiol Med 1996, 91:817-818.
36. Levy H., Hurwitz M.D., Strimling M., et al. Ankylosing spondylitis lung disease and Mycobacterium scrofulaceum. Br J Dis Chest 1988, 82:84-87.
37. Libshitz H.I., Atkinson G.W. Pulmonary cystic disease in ankylosing spondylitis: two cases with unusual superinfection. J Can Assoc Radiol 1978, 29:266-268.
38. Lee C.C., Lee S.H., Chang I.J., et al. Spontaneous pneumothorax associated with ankylosing spondylitis. Rheumatology 2005, 44:1538-1541.
39. Wang C.T., Tsen J.C., Lin H.J., et al. Bilateral spontaneous pneumothorax in a patient with ankylosing spondylitis. Eur J Emerg Med 2007, 14(2):123-124.
40. Erb N., Karokis D., Delamere J.P., et al. Obstructive sleep apnea as a cause of fatigue in ankylosing spondylitis. Ann Rheum Dis 2003, 62:183-184.
41. Solak O., Fidan F., Dundar U., et al. The prevalence of obstructive sleep apnea syndrome in ankylosing spondylitis patients. Rheumatology 2009, 48:433-435.
42. Gran J.T., Skomsvoll J.F. The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 1997, 36:766-771.
43. Lehtinen K. Cause of death in 79 patients with ankylosing spondylitis. Scand J Rheumatol 1980, 9:145-147.
44. Averns H.L., Oxtoby J., Taylor H.G., et al. Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol 1996, 25:138-142.
45. Eghtedari A.A., Davis P., Bacon P.A. Immunological reactivity in ankylosing spondylitis: circulating immunoblasts, autoantibodies, and immunoglobulins. Ann Rheum Dis 1976, 35:155-157.
46. Scherak O., Kolarz G., Popp W., et al. Lung involvement in rheumatoid factor-negative arthritis. Scand J Rheumatol 1993, 22:225-228.
47. Wendling D., Dalphin J.C., Toson B., et al. Bronchoalveolar lavage in ankylosing spondylitis. Ann Rheum Dis 1990, 49:325-326.
48. Feltelius N., Hedenstrom H., Hillerdal G., et al. Pulmonary involvement in ankylosing spondylitis. Ann Rheum Dis 1986, 45:736-740.
49. Franssen M.J.A.M., van Herwaarden C.L.A., van de Putte L.B.A., et al. Lung function in patients with ankylosing spondylitis. A study of the influence of disease activity and treatment with nonsteroidal antiinflammatory drugs. J Rheumatol 1986, 13:936-940.
50. Van Noord J.A., Cauberghs M., Van de Woestijne K.P., et al. Total respiratory resistance and reactance in ankylosing spondylitis and kyphoscoliosis. Eur Respir J 1991, 4:945-951.
51. Vanderschueren D., Decramer M., van den Daele P., et al. Pulmonary function and maximal transrespiratory pressures in ankylosing spondylitis. Ann Rheum Dis 1989, 48:632-635.
52. Fisher L.R., Cawley M.I.D., Holgate S.T. Relation between chest expansion, pulmonary function, and exercise tolerance in patients with ankylosing spondylitis. Ann Rheum Dis 1990, 49:921-925.
53. Elliott C.G., Hill T.R., Adams T.E., et al. Exercise performance of subjects with ankylosing spondylitis and limited chest expansion. Bull Eur Physiopathol Respir 1985, 21:363-368.
54. Chakera T.M.H., Howarth F.H., Kendall M.J., et al. The chest radiograph in ankylosing spondylitis. Clin Radiol 1975, 26:455-460.
55. Fenlon H.M., Casserly I., Sant S.M., et al. Plain radiographs and thoracic high-resolution CT in patients with ankylosing spondylitis. AJR Am J Roentgenol 1997, 168:1067-1072.
56. Casserly I.P., Fenlon H.M., Breatnach E., et al. Lung findings on high-resolution computed tomography in idiopathic ankylosing spondylitis-correlation with clinical findings, pulmonary function testing and plain radiography. Br J Rheumatol 1997, 36:677-682.
57. Turetschek K., Ebner W., Fleischman D., et al. Early pulmonary involvement in ankylosing spondylitis: assessment with thin-section CT. Clin Radiol 2000, 55:632-636.
58. Souza A.S., Muller N.L., Marchiori E., et al. Pulmonary abnormalities in ankylosing spondylitis. J Thorac Imaging 2004, 19:259-263.
59. Rhagae P.K., Tarrasa B.C. Bronchocentric granulomatosis and ankylosing spondylitis. Thorax 1984, 39:317-318.
60. Turner J.F., Ensnarer R.J. Bronchiolitis obliterans and organizing pneumonia associated with ankylosing spondylitis. Arthritis Rheum 1994, 37:1557-1559.
61. Braun J., Brandt J., Listing J., et al. Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicentre trial. Lancet 2002, 359:1187-1193.
62. Davis J.C., Van Der Heijde D., et al. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 2003, 48:3230-3236.
63. Van Der Heijde D., Schiff M.H., Seiper J., et al. Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long term results from the ATLAS trial. Ann Rheum Dis 2009, 68:922-929.
64. Richly D.J., Dipper J.T. Infections associated with tumor necrosis factor-α antagonists. Pharmacotherapy 2005, 25(9):1181-1192.
65. Desai S.B., First D.E. Problems encountered during anti-tumor necrosis factor therapy. Best Pract Res Clin Rheumatol 2006, 20(4):757-790.
66. Carmona L., Gomez-Rein J.J., Rodríguez-Valverde V., et al. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 2005, 52(6):1766-1772.
67. Bodur H., Eser F., Konca S., et al. Infliximab-induced lupus-like syndrome in a patient with ankylosing spondylitis. Rheumatol Int 2009, 29(4):451-454.
68. Gonzalez-Lopez M.A., Blanco R., González-Vela M.C., et al. Development of sarcoidosis during etanercept therapy. Arthritis Rheum 2005, 55(5):817-820.